InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: jessellivermore post# 27438

Monday, 05/12/2014 12:41:36 PM

Monday, May 12, 2014 12:41:36 PM

Post# of 426269
Yes, unfortunatelly the managment did not do a great job. If I balance it 10-20% of management and 80-90% of FDA fault.

Ajax: I really do not understand the difference between ANCHOR and "to market Vascepa for Trgs >200mg/dl. but to clearly state that there is no proof as yet that it lowers CVE's."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News